We are live on ! Find out more
FEED

ENvue Medical Inc

8 hedge funds and large institutions have $123K invested in ENvue Medical Inc in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.02% less ownership

Funds ownership: 0.07%0.05% (-0.02%)

20% less funds holding

Funds holding: 108 (-2)

49% less capital invested

Capital invested by funds: $242K → $123K (-$119K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FEED Hedge Fund Activity: Q4 2023 in Review

8 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q4 2023, worth a combined $123K — down 49% from $242K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FEED and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $46K. The largest seller was Armistice Capital, exiting entirely with an estimated $57.2K sold.

  • 8 institutional investors held ENvue Medical Inc (FEED) as of Q4 2023, down from 10 in Q3 2023.
  • Funds reported $123K of ENvue Medical Inc stock for Q4 2023, down 49% quarter-over-quarter.
  • 1 fund opened new ENvue Medical Inc positions in Q4 2023 and 3 closed out, a net change of -2 holders.
  • The largest ENvue Medical Inc buyer in Q4 2023 was Renaissance Technologies, an estimated $46K added.
  • The largest ENvue Medical Inc seller in Q4 2023 was Armistice Capital, an estimated $57.2K sold.

Based on aggregated 13F filings for Q4 2023.